Clinical Trial Update: Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial of cobiprostone in portal hypertension was terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Hypertension

Drugs mentioned

• cobiprostone (cobiprostone)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Portal Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2016-03-16